Featured Articles

81. Dancing In The Bioprocessing Ballroom: Voices Of Experience 12/7/2018

    Single-use technology is well-established and made its way into commercial licensed facilities, but there is more innovation in this field which will enhance its versatility into new markets and technologies.

82. Utilizing External Collaboration To Accelerate Vaccine Development 11/2/2018

    Securing a partner to serve as an extension of Janssen’s Biotherapeutics Development API-Large Molecule team was essential to reduce both risk and the time needed for delivery of clinical supplies.

83. Raw Material Variability Control: Where Do We Go From Here? 10/26/2018

    Cory Card, Principal Scientist, discusses not just ideas shared at a recent industry symposium on raw material variability control, but, most importantly, where to go from here.

84. Amgen's Digital Transformation: Link Suppliers' Raw Material Data To Patients 10/19/2018

    Using its Supplier Relationship Excellence program, Amgen opened the lines of communication with suppliers and created a feedback loop where data can be shared to optimize operational performance. 

85. Making The Business Case For Vaccine Manufacturing 10/10/2018

    Vaccines are absolutely crucial for maintaining global health, but are a challenge to develop and manufacture. How can businesses ensure profitability while providing low prices for developing countries?

86. Why Invest In Emerging Markets Now 10/10/2018

    Unexplored and emerging markets are an attractive prospect for biopharma companies looking to expand. But when it comes to ensuring success, what’s the wisest way to invest?

87. Balancing Stainless, Single-Use, And Continuous Manufacturing 9/21/2018

    Several drivers affect how the appropriate facility design and unit operations for a process are selected, making it imperative to properly evaluate each option. 

88. The Past And Future Of Managing Raw Material And Process Risks In Biomanufacturing 9/18/2018

    How far have we come in raw material supply management, and what still needs accomplished to ensure the delivery of safe and effective drugs?

89. How A New Factory-In-A-Box Is Helping Scale Up Manufacturing Of Viral Vector Based Therapies To Reach More Patients 8/31/2018

    Manufacturing viral vector-based therapies such as vaccines and gene and cell therapies is complex, but a new manufacturing solution helps solve those challenges.

90. FUJIFILM Diosynth Biotechnologies Drives Flexibility And Efficiency In Their Biomanufacturing Platform Using Integrated Automation 8/30/2018

    Through a successful implementation, FUJIFILM Diosynth was able to not only recognize the benefits that an integrated automation platform offers but also the importance of working with an experienced partner.